1999 年至 2010 年美国 26 至 39 岁女性沙眼衣原体感染。
Chlamydia trachomatis infection among women 26 to 39 years of age in the United States, 1999 to 2010.
机构信息
Surveillance and Data Management Branch, Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
出版信息
Sex Transm Dis. 2013 Apr;40(4):335-7. doi: 10.1097/OLQ.0b013e31827cd60d.
Abstract
Using data from a nationally representative survey, we identified predictors of chlamydial infection in women aged 26 to 39 years. Chlamydia prevalence was low overall but varied by sociodemographics and sexual behaviors. Findings support current recommendations that women older than 25 years should not be routinely screened for chlamydial infection.
摘要
利用一项全国代表性调查的数据，我们确定了 26 至 39 岁女性中衣原体感染的预测因素。总体而言，衣原体感染率较低，但存在社会人口统计学和性行为方面的差异。这些发现支持了目前的建议，即 25 岁以上的女性不应常规筛查衣原体感染。
相似文献
1
Chlamydia trachomatis infection among women 26 to 39 years of age in the United States, 1999 to 2010.
Sex Transm Dis. 2013 Apr;40(4):335-7. doi: 10.1097/OLQ.0b013e31827cd60d.
2
Cost-benefit analysis of Chlamydia trachomatis screening in pregnant women in a high burden setting in the United States.
BMC Infect Dis. 2017 Feb 18;17(1):155. doi: 10.1186/s12879-017-2248-5.
3
Chlamydia trachomatis infections in female military recruits.
N Engl J Med. 1998 Sep 10;339(11):739-44. doi: 10.1056/NEJM199809103391105.
4
Control of Chlamydia trachomatis infections in female army recruits: cost-effective screening and treatment in training cohorts to prevent pelvic inflammatory disease.
Sex Transm Dis. 1999 Oct;26(9):519-26. doi: 10.1097/00007435-199910000-00007.
5
Screening for Chlamydia trachomatis in asymptomatic women in Hungary. An epidemiological and cost-effectiveness analysis.
Acta Obstet Gynecol Scand. 2001 Apr;80(4):300-6. doi: 10.1034/j.1600-0412.2001.080004300.x.
6
Chlamydia trachomatis: common misperceptions and misunderstandings.
J Pediatr Adolesc Gynecol. 2005 Aug;18(4):231-43. doi: 10.1016/j.jpag.2005.05.002.
7
Should all sexually active young women in Hungary be screened for Chlamydia trachomatis?
Eur J Obstet Gynecol Reprod Biol. 2003 Jan 10;106(1):55-9. doi: 10.1016/s0301-2115(02)00222-1.
8
[Screening for asymptomatic Chlamydia trachomatis infection: cost-effectiveness favorable at a minimum prevalence rate of 3% or more].
Ned Tijdschr Geneeskd. 2001 Mar 10;145(10):499-501.
9
Screening for Chlamydia trachomatis infection in pregnant women in Martinique.
Sex Transm Dis. 1995 Jul-Aug;22(4):221-7. doi: 10.1097/00007435-199507000-00004.
10
Prevalence of Chlamydia trachomatis among young German adolescents, 2005-06.
Sex Health. 2011 Mar;8(1):120-2. doi: 10.1071/SH10036.
引用本文的文献
1
Incorporation of Social Determinants of Health in the Peer-Reviewed Literature: A Systematic Review of Articles Authored by the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.
Public Health Rep. 2018 Jul/Aug;133(4):392-412. doi: 10.1177/0033354918774788. Epub 2018 Jun 6.
2
Highly sensitive and novel point-of-care system, aQcare Chlamydia TRF kit for detecting Chlamydia trachomatis by using europium (Eu) (III) chelated nanoparticles.
Ann Lab Med. 2015 Jan;35(1):50-6. doi: 10.3343/alm.2015.35.1.50. Epub 2014 Dec 8.
本文引用的文献
1
National health and nutrition examination survey: analytic guidelines, 1999-2010.
Vital Health Stat 2. 2013 Sep(161):1-24.
2
The National Health and Nutrition Examination Survey: Sample Design, 1999-2006.
Vital Health Stat 2. 2012 May(155):1-39.
3
Chlamydia trachomatis trends in the United States among persons 14 to 39 years of age, 1999-2008.
Sex Transm Dis. 2012 Feb;39(2):92-6. doi: 10.1097/OLQ.0b013e31823e2ff7.
4
CDC Grand Rounds: Chlamydia prevention: challenges and strategies for reducing disease burden and sequelae.
MMWR Morb Mortal Wkly Rep. 2011 Apr 1;60(12):370-3.
5
A paradox: overscreening of older women for Chlamydia while too few younger women are being tested.
Sex Transm Dis. 2011 Feb;38(2):130-2. doi: 10.1097/OLQ.0b013e3182027e00.
6
Chlamydia screening of young sexually active, Medicaid-insured women by race and ethnicity, 2002-2005.
Sex Transm Dis. 2009 Oct;36(10):642-6. doi: 10.1097/OLQ.0b013e3181ab481b.
7
Social determinants and sexually transmitted disease disparities.
Sex Transm Dis. 2008 Dec;35(12 Suppl):S13-8. doi: 10.1097/OLQ.0b013e31818d3cad.
8
The program cost and cost-effectiveness of screening men for Chlamydia to prevent pelvic inflammatory disease in women.
Sex Transm Dis. 2008 Nov;35(11 Suppl):S66-75. doi: 10.1097/OLQ.0b013e31818b64ac.
9
Measurement of socioeconomic status in health disparities research.
J Natl Med Assoc. 2007 Sep;99(9):1013-23.
10
Screening for Chlamydia trachomatis: a systematic review of the economic evaluations and modelling.
Sex Transm Infect. 2006 Jun;82(3):193-200; discussion 201. doi: 10.1136/sti.2005.017517.
Zotero 插件